Criticality of Benzoyl Peroxide and Antibiotic Fixed Combinations in Combating Rising Resistance in Cutibacterium acnes.

IF 1.9 4区 医学 Q3 DERMATOLOGY
Clinical, Cosmetic and Investigational Dermatology Pub Date : 2025-03-31 eCollection Date: 2025-01-01 DOI:10.2147/CCID.S506254
Mahmoud Ghannoum, Ahmed Gamal, Ahmed Kadry, James Q Del Rosso, Linda Stein Gold, Leon H Kircik, Julie C Harper
{"title":"Criticality of Benzoyl Peroxide and Antibiotic Fixed Combinations in Combating Rising Resistance in <i>Cutibacterium acnes</i>.","authors":"Mahmoud Ghannoum, Ahmed Gamal, Ahmed Kadry, James Q Del Rosso, Linda Stein Gold, Leon H Kircik, Julie C Harper","doi":"10.2147/CCID.S506254","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antibiotic resistance is growing globally, with multiple countries reporting resistance in >50% of <i>Cutibacterium acnes</i> (<i>C. acnes</i>) strains. Combination formulations of an antibiotic and the antimicrobial benzoyl peroxide (BPO) may reduce this resistance risk, especially with prolonged use. This 4-part study tested susceptibility of 31 <i>C. acnes</i> clinical strains and development of resistance to antibiotics alone or combined with BPO.</p><p><strong>Methods: </strong><i>C. acnes</i> susceptibility to single-drug antibiotics was assessed via minimum inhibitory concentration (MIC) values obtained from epsilometer tests, with lower MIC indicating higher susceptibility. Susceptibility to fixed-dose antibiotic/BPO combination products was determined by measuring the zone of inhibition using the agar diffusion method, with larger diameter indicating increased bacterial inhibition. The effect (synergistic, additive, antagonistic, or indifferent [no interaction]) of combining clindamycin with BPO on <i>C. acnes</i> inhibition was evaluated using a checkerboard assay, wherein 2 test compounds are combined in varying concentrations. Resistance development was assessed using serial passage of bacterial cultures in increasing concentrations of clindamycin alone or in combination with BPO.</p><p><strong>Results: </strong>All tested antibiotics (clindamycin, doxycycline, erythromycin, and minocycline) exhibited similar activity. <i>C. acnes</i> susceptibility was variable, with some strains having elevated MIC values-an indication of resistance-against different antibiotics. For 6 strains resistant to clindamycin alone (inhibitory zone=0 cm), formulations with BPO enhanced activity against the same isolates (range: 0.8-2.2 cm). Of 7 acne-associated strains, combining clindamycin and BPO had an additive effect against 4, and no interaction against 3. Bacterial cultures repeatedly exposed to the combination of clindamycin and BPO did not develop antibiotic resistance, which occurred with exposure to clindamycin alone.</p><p><strong>Conclusion: </strong>Overall, antibiotic susceptibility was highly dependent on the <i>C. acnes</i> strain, and antibiotic formulations with BPO exhibited enhanced activity against less susceptible strains. Fixed combinations of BPO with an antibiotic may improve antimicrobial activity and protect against resistance development.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"18 ","pages":"755-766"},"PeriodicalIF":1.9000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970427/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical, Cosmetic and Investigational Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CCID.S506254","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Antibiotic resistance is growing globally, with multiple countries reporting resistance in >50% of Cutibacterium acnes (C. acnes) strains. Combination formulations of an antibiotic and the antimicrobial benzoyl peroxide (BPO) may reduce this resistance risk, especially with prolonged use. This 4-part study tested susceptibility of 31 C. acnes clinical strains and development of resistance to antibiotics alone or combined with BPO.

Methods: C. acnes susceptibility to single-drug antibiotics was assessed via minimum inhibitory concentration (MIC) values obtained from epsilometer tests, with lower MIC indicating higher susceptibility. Susceptibility to fixed-dose antibiotic/BPO combination products was determined by measuring the zone of inhibition using the agar diffusion method, with larger diameter indicating increased bacterial inhibition. The effect (synergistic, additive, antagonistic, or indifferent [no interaction]) of combining clindamycin with BPO on C. acnes inhibition was evaluated using a checkerboard assay, wherein 2 test compounds are combined in varying concentrations. Resistance development was assessed using serial passage of bacterial cultures in increasing concentrations of clindamycin alone or in combination with BPO.

Results: All tested antibiotics (clindamycin, doxycycline, erythromycin, and minocycline) exhibited similar activity. C. acnes susceptibility was variable, with some strains having elevated MIC values-an indication of resistance-against different antibiotics. For 6 strains resistant to clindamycin alone (inhibitory zone=0 cm), formulations with BPO enhanced activity against the same isolates (range: 0.8-2.2 cm). Of 7 acne-associated strains, combining clindamycin and BPO had an additive effect against 4, and no interaction against 3. Bacterial cultures repeatedly exposed to the combination of clindamycin and BPO did not develop antibiotic resistance, which occurred with exposure to clindamycin alone.

Conclusion: Overall, antibiotic susceptibility was highly dependent on the C. acnes strain, and antibiotic formulations with BPO exhibited enhanced activity against less susceptible strains. Fixed combinations of BPO with an antibiotic may improve antimicrobial activity and protect against resistance development.

过氧化苯甲酰与抗生素固定组合在对抗痤疮表皮杆菌耐药性上升中的重要性。
背景:抗生素耐药性正在全球范围内增长,多个国家报告了50%的痤疮表皮杆菌(C. acnes)菌株的耐药性。抗生素和抗微生物药物过氧化苯甲酰(BPO)的联合制剂可降低这种耐药风险,特别是长期使用。本研究分为4个部分,检测31株痤疮C.临床菌株的敏感性,以及对抗生素单独或联合BPO的耐药情况。方法:通过epsilometer试验获得的最低抑制浓度(MIC)值来评估痤疮C.对单药抗生素的敏感性,MIC越低表明敏感性越高。对固定剂量抗生素/BPO组合产品的敏感性采用琼脂扩散法测定抑制区,直径越大表明细菌抑制作用越强。使用棋盘法评估克林霉素与BPO联合使用对痤疮C.的抑制作用(协同、加性、拮抗或无相互作用),其中两种测试化合物以不同浓度联合使用。通过增加克林霉素单独或与BPO联合浓度的连续传代细菌培养来评估耐药性的发展。结果:所有抗生素(克林霉素、强力霉素、红霉素和米诺环素)均表现出相似的活性。痤疮芽孢杆菌的敏感性是可变的,一些菌株对不同抗生素的MIC值升高,这是一种耐药性的指示。对于6株对克林霉素单独耐药的菌株(抑菌带=0 cm),添加BPO的制剂对相同的菌株(抑菌带:0.8-2.2 cm)具有增强的活性。在7株痤疮相关菌株中,克林霉素与BPO联合对4株有加性作用,对3株无互作作用。反复暴露于克林霉素和BPO组合的细菌培养物不会产生抗生素耐药性,而单独暴露于克林霉素时则会产生耐药性。结论:总体而言,抗生素敏感性高度依赖于痤疮C.菌株,含有BPO的抗生素制剂对较不敏感的菌株具有增强的活性。BPO与抗生素的固定组合可以提高抗菌活性并防止耐药性的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
4.30%
发文量
353
审稿时长
16 weeks
期刊介绍: Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions. Normal and pathological processes in skin development and aging, their modification and treatment, as well as basic research into histology of dermal and dermal structures that provide clinical insights and potential treatment options are key topics for the journal. Patient satisfaction, preference, quality of life, compliance, persistence and their role in developing new management options to optimize outcomes for target conditions constitute major areas of interest. The journal is characterized by the rapid reporting of clinical studies, reviews and original research in skin research and skin care. All areas of dermatology will be covered; contributions will be welcomed from all clinicians and basic science researchers globally.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信